Back
Quanterix Corp. 10K Form
Buy
60
QTRX
Quanterix Corp.
Last Price:
$7.71
Seasonality Move:
3.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-04 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2020-05-07 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2020-03-13 | 10K | QTRX/Quanterix Corp. Annual |
| 2019-11-08 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2019-08-06 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2019-05-10 | 10Q | QTRX/Quanterix Corp. Quarterly |
Receive QTRX News And Ratings
See the #1 stock for the next 7 days that we like better than QTRX
QTRX Financial Statistics
Sales & Book Value
| Annual Sales: | $137.4M |
|---|---|
| Cash Flow: | $-41.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.74 |
| Price / Book: | 1.11 |
Profitability
| EPS (TTM): | -2.33060 |
|---|---|
| Net Income (TTM): | $-95.7M |
| Gross Margin: | $83.1M |
| Return on Equity: | -30.04% |
| Return on Assets: | -23.46% |
Quanterix Corp. Earnings Forecast
Key Quanterix Corp. Financial Ratios
-
The Gross Profit Margin over the past 10 years for QTRX is 60.47%.
-
The Selling, General & Administrative Expenses for QTRX have been equal to 76.14% of Gross Profit Margin.
-
The Research & Development expenses have been 22.62% of Revenue.
-
The Net Earning history of QTRX is -28.04% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 3 years.
Quanterix Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | QTRX |
| CUSIP: | 74766Q |
| Website: | quanterix.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 3.02 |
| Quick Ratio: | 2.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
QTRX Technical Analysis vs Fundamental Analysis
Buy
60
Quanterix Corp. (QTRX)
is a Buy
Is Quanterix Corp. a Buy or a Sell?
-
Quanterix Corp. stock is rated a BuyThe current Quanterix Corp. [QTRX] share price is $7.48. The Score for QTRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.